Back to EPRX

CITADEL ADVISORS LLC → EPRX

CITADEL ADVISORS LLC EPRX Position History

Eupraxia Pharmaceuticals Inc. • Healthcare

Quarters held
8
Latest value
$644K
Q2 2026
Peak value
$2.7M
First seen
Q1 2025

Dollar value over time

Show data table
PeriodPosition value
Q1 2025$39K
Q2 2025$108K
Q1 2026$1.6M
Q1 2026$102K
Q2 2026$2.7M
Q2 2026$644K
Q2 2026$2.7M
Q2 2026$644K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q2 2026$644K97.4K——
Q2 2026$2.7M404.6K——
Q2 2026$644K97.4K——
Q2 2026$2.7M404.6K——
Q1 2026$102K14.1K——
Q1 2026$1.6M216.1K——
Q2 2025$108K18.2K——
Q1 2025$39K12.1K——

Other funds holding EPRX

Other CITADEL ADVISORS LLC positions

ETHA

ISHARES TR

$13.2B
ETHA

ISHARES TR

$13.2B
SPY

SPDR S&P 500 ETF TR

$3B
ETHA

ISHARES TR

$2.7B
SPY

SPDR S&P 500 ETF TR

$2.6B
NVDA

NVIDIA CORPORATION

$2.1B
SPY

SPDR S&P 500 ETF TR

$2.1B
NVDA

NVIDIA CORPORATION

$2.1B